119
Participants
Start Date
May 31, 2014
Primary Completion Date
July 4, 2016
Study Completion Date
February 28, 2023
Atezolizumab
Atezolizumab 1200 mg will be given by IV infusion on Day 1 of 21-day cycles until disease progression per RECIST v1.1 criteria or unmanageable toxicity.
NYU Langone Medical Center, New York
Mount Sinai School of Medicine - Tisch Cancer Institute, New York
Memorial Sloan-Kettering Cancer Center, New York
Charité - Universitätsmedizin Berlin; CC 8: Chirurgische Medizin; Klinik für Urologie, Berlin
New York Oncology Hematology, P.C., Albany
Kimmel Cancer Center Thomas Jefferson University, Philadelphia
Georgetown University Medical Center Lombardi Cancer Center, Washington D.C.
Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milan
Universitätsklinikum Hamburg-Eppendorf Onkologisches Zentrum Medizinische Klinik II, Hamburg
Virginia Cancer Specialists, PC, Fairfax
Virginia Oncology Associates - Lake Wright Cancer Center, Norfolk
Hospital General Universitario Gregorio Marañon; Servicio de Oncologia, Madrid
Hospital Ramon y Cajal; Servicio de Oncologia, Madrid
Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid
Piedmont Cancer Institute, PC, Atlanta
Clinica Universitaria de Navarra; Servicio de Oncologia, Pamplona
Mayo Clinic Cancer Center, Jacksonville
University of Alabama At Birmingham, Birmingham
Sarah Cannon Cancer Center - Tennessee Oncology, Pllc, Nashville
Universitätsklinikum Düsseldorf; Urologische Klinik, Düsseldorf
Norton Cancer Institute, Louisville
Hospital Universitario Virgen del Rocio; Servicio de Oncologia, Seville
Case Western Reserve Univ; Hem/Onc, Cleveland
Cleveland Clinic, Cleveland
Oncology Hematology Care Inc, Cincinnati
Indiana University Health; Goshen Center for Cancer Care, Goshen
University of Michigan Comprehensive Cancer Center, Ann Arbor
Karmanos Cancer Institute, Detroit
Azienda USL8 Arezzo-Presidio Ospedaliero 1 San Donato;U.O.C. Oncologia, Arezzo
Minnesota Oncology Minneapolis, Minneapolis
Mayo Clinic - Rochester, Rochester
Ingalls Memorial Hospital, Harvey
University of Chicago; Hematology/Oncology, Chicago
Urology Cancer Center & GU Research Network, Omaha
APHP - Hospital Saint Louis, Paris
Ctr for Cancer and Blood Disorders, Fort Worth
Texas Oncology - Houston (Gessner), Houston
Houston Methodist Hospital, Houston
University of Texas Health Science Center at San Antonio, San Antonio
Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie, Freiburg im Breisgau
Rocky Mountain Cancer Center - Aurora, Aurora
University Of Colorado, Aurora
Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik, München
Pinnacle Oncology Hematology, Scottsdale
Arizona Oncology - HOPE Wilmot, Tucson
Comprehensive Cancer Centers of Nevada, Las Vegas
UCLA, Los Angeles
The Angeles Clinic and Research Institute - W LA Office, Los Angeles
USC Norris Cancer Center, Los Angeles
Kaiser Permanente - San Marcos, San Marcos
Hopital Foch; Oncologie, Suresnes
Kaiser Permanente; Oncology Clinical Trials, Vallejo
Institut Gustave Roussy; Oncologie Medicale, Villejuif
Seattle Cancer Care Alliance, Seattle
UCSF, San Francisco
Stanford Cancer Center, Stanford
University of Connecticut Health Center, Farmington
Yale Cancer Center ; Medical Oncology, New Haven
Massachusetts General Hospital;Oncology, Boston
Dana Farber Cancer Inst. ; Dept. of Medical Oncology, Boston
Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Boston
Willamette Valley Cancer Ctr - 520 Country Club, Eugene
Bcca - Cancer Center Southern Interior, Kelowna
BCCA-Vancouver Cancer Centre, Vancouver
Lakeridge Health Oshawa; Oncology, Oshawa
The Ottawa Hospital Cancer Centre; Oncology, Ottawa
Sunnybrook Odette Cancer Centre, Toronto
University Health Network; Princess Margaret Hospital; Medical Oncology Dept, Toronto
McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal
The Netherlands Cancer Institute - Antoni Van Leeuwenhoekziekenhuis, Amsterdam
Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona
Institut Catala d Oncologia Hospital Duran i Reynals, Barcelona
University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital, Birmingham
Barts and The London, London
Sarah Cannon Research Institute, London
The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral
Royal Marsden Hospital; Dept of Medical Oncology, Sutton
Hoffmann-La Roche
INDUSTRY